PTN trade ideas

meitshel Updated 

Palatin Technologies Inc is a part of the healthcare sector. The company is engaged in developing targeted, receptor-specific peptide therapeutics for the treatment of diseases with unmet medical needs and commercial potential. Its programs are based on molecules that modulate the activity of the melanocortin and natriuretic peptide receptor systems. Its main...

meitshel Updated 

This is not a financial advice! Lots of upcoming catalysts in 2024 Vol . is slowly increasing SL under 2.2 TP approx. 9.0 If the catalysts will be positive, this can fly way higher! Most info on the chart. Trade carefully!

fluffystat

Enter if it breaks this flag/triangle pattern on the 15-1 hr timeframe, putting your stop loss just below the candle you enter on. Close some of your position after a few hours. Close the entire position when price closes below the 10 SMA. sorry I meant to tag this as "long" ~this is just an idea~ ~use paper trading money instead of real money~

muhley

This pattern gives a first target to return to level A at about 8.10-8.20 and a second target to return to level C at around 8.50. Anticipated Catalysts for remaining 2022: NA/US Licensing Vyleesi ROW Licensing Vyleesi PL3994 PH2 Heart Failure Data Diabetic Nephropathy PH 2 Initiate Study Something should also happen with the preferred shares at the end...

muhley

Watching for breakout here for $12-16 target. Coming off of lows with multiple catalysts coming up.

muhley

Looking for the $12 target after this pattern confirmed.

Ameanchink

Fib retrace will happen within the next 4 weeks. Lowest analyst price target is 2.00 which is 800%

BADQOMOCAWGOWLD

$PTN H.C. Wainwright analyst Joseph Pantginis is behind today’s news as he reiterated the firm’s buy rating for PTN stock. To go along with that, Pantginis also increased the price target for PTN stock from $2 per share to $5 per share, 1,371% upside Palatin Technologies, Inc., a biopharmaceutical company, develops targeted receptor-specific therapeutics for the...

thedailyinvestor

Company Profile Sector: Health Care Industry: Biotechnology Company Location: Cranbury, NJ Palatin Technologies, Inc., a biopharmaceutical company, develops targeted receptor-specific therapeutics for the treatment of various diseases in the United States. The company's lead product is Vyleesi, a melanocortin receptor (MCr) agonist for the treatment of...

muhley

I really don't see it going below the green line. Good time to load up imo.

bullbearhogewes

These thoughts are my own ideas based off my own analysis. Please do your own research before putting your own money into the markets.

muhley

I just created this chart to better understand how PTN moved on the big spike recently. Seems like it didn't take much, just a Yahoo article after the positive dry eye news and then a few YouTube videos. Here are the links to the article and videos: 12/22/2020 Michael Marcus -...

muhley

Short Term - Break .61-.62 for .75 target. Long Term - Expect NA and ROW licensing deals to push above $2 before the end of 2021.

SatoriTrades

PTN gave a nice buy signal. I personally took a position here. There is a chance it could test 0.40 cent area. Stoploss below white line, take profits at colored lines above green. THIS IS NOT FINANCIAL ADVICE. DO NOT BLINDLY FOLLOW THIS TRADE.

muhley

Let's see if volume confirms this breakout. A lot going on with this company right now. I believe with the Key Opinion Leader webinar tomorrow they are trying to increase institutional buying and possibly analyst coverage. Volatility with the stock over the past 5 years has allowed quite a bit of opportunity to repeatedly buy below .60 and sell above 1.20.

muhley

Chart gives ~.72 target. Also breaking above 200MA

muhley

This is about 40% return if it hits this upper target.

muhley

Although my target based on fundamentals is much higher for PTN. This harmonic pattern gives a .72 target. Link below to my other PTN idea with fundamental outlooks on how we look moving forward.